Cardiovascular Effects of <scp>GLP</scp> ‐1 Receptor Agonists Across Age Groups: An Updated Meta‐Analysis of Randomized Controlled Trials

Ai Fujii, Masashi Hasebe, Kengo Furuichi, Daisuke Yabe, Satoshi Yoshiji

Open source

DOI
10.1111/dom.71496
Published
2026-10-27
Container
Diabetes, Obesity and Metabolism
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71496,
  title = {Cardiovascular Effects of
                    <scp>GLP</scp>
                    ‐1 Receptor Agonists Across Age Groups: An Updated Meta‐Analysis of Randomized Controlled Trials},
  author = {Ai Fujii and Masashi Hasebe and Kengo Furuichi and Daisuke Yabe and Satoshi Yoshiji},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.71496},
  url = {https://doi.org/10.1111/dom.71496}
}

RIS

TY  - JOUR
TI  - Cardiovascular Effects of
                    <scp>GLP</scp>
                    ‐1 Receptor Agonists Across Age Groups: An Updated Meta‐Analysis of Randomized Controlled Trials
AU  - Ai Fujii
AU  - Masashi Hasebe
AU  - Kengo Furuichi
AU  - Daisuke Yabe
AU  - Satoshi Yoshiji
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.71496
UR  - https://doi.org/10.1111/dom.71496
ER  - 

APA

Fujii, A., Hasebe, M., Furuichi, K., Yabe, D., & Yoshiji, S. (2026). Cardiovascular Effects of <scp>GLP</scp> ‐1 Receptor Agonists Across Age Groups: An Updated Meta‐Analysis of Randomized Controlled Trials. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71496

Source records